- Home
- HOWL vs EMCG Comparison
HOWL vs EMCG Comparison
Compare HOWL & EMCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- EMCG
- Stock Information
- Founded
- HOWL 2017
- EMCG 2021
- Country
- HOWL United States
- EMCG United States
- Employees
- HOWL N/A
- EMCG N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- EMCG
- Sector
- HOWL Health Care
- EMCG
- Exchange
- HOWL Nasdaq
- EMCG NYSE
- Market Cap
- HOWL 87.4M
- EMCG 83.7M
- IPO Year
- HOWL 2021
- EMCG 2022
- Fundamental
- Price
- HOWL $1.79
- EMCG $11.64
- Analyst Decision
- HOWL Strong Buy
- EMCG
- Analyst Count
- HOWL 2
- EMCG 0
- Target Price
- HOWL $13.50
- EMCG N/A
- AVG Volume (30 Days)
- HOWL 656.6K
- EMCG 3.5K
- Earning Date
- HOWL 11-07-2024
- EMCG 01-01-0001
- Dividend Yield
- HOWL N/A
- EMCG N/A
- EPS Growth
- HOWL N/A
- EMCG N/A
- EPS
- HOWL N/A
- EMCG 0.23
- Revenue
- HOWL $3,386,000.00
- EMCG N/A
- Revenue This Year
- HOWL N/A
- EMCG N/A
- Revenue Next Year
- HOWL $191.98
- EMCG N/A
- P/E Ratio
- HOWL N/A
- EMCG $49.82
- Revenue Growth
- HOWL N/A
- EMCG N/A
- 52 Week Low
- HOWL $1.58
- EMCG $10.87
- 52 Week High
- HOWL $8.19
- EMCG $13.39
- Technical
- Relative Strength Index (RSI)
- HOWL 32.55
- EMCG 65.46
- Support Level
- HOWL $1.58
- EMCG $11.63
- Resistance Level
- HOWL $2.24
- EMCG $11.62
- Average True Range (ATR)
- HOWL 0.16
- EMCG 0.00
- MACD
- HOWL -0.09
- EMCG 0.00
- Stochastic Oscillator
- HOWL 7.01
- EMCG 100.00
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About EMCG EMBRACE CHANGE ACQUISITION CORP
Embrace Change Acquisition Corp is a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses.